Scientific and clinical progress together with the development of effective novel therapeutic
options has engendered multiple important changes in the diagnosis and management of …

Abstract Background We published the Canadian 2003 International Consensus Algorithm
for the Diagnosis, Therapy, and Management of Hereditary Angioedema (HAE; C1 inhibitor …

Hereditary Angioedema (HAE) is a rare and disabling disease for which early diagnosis and
effective therapy are critical. This revision and update of the global WAO/EAACI guideline on …

Angioedema is defined as localized and self‐limiting edema of the subcutaneous and
submucosal tissue, due to a temporary increase in vascular permeability caused by the …

Hereditary Angioedema (HAE) is a rare disease and for this reason proper diagnosis and
appropriate therapy are often unknown or not available for physicians and other health care …

Hereditary angio-oedema is caused by a heterozygous deficiency of C1 inhibitor. This
inhibitor regulates several inflammatory pathways, and patients with hereditary angio …

Background Hereditary angio‐oedema (HAE) is a rare disease caused by deficiency of
complement C1 inhibitor (C1 inhibitor). The diagnosis is challenging as the disease can …

Acquired angioedema (AAE) is characterized by acquired deficiency of C1 inhibitor (C1-
INH), hyperactivation of the classical pathway of human complement and angioedema …

BACKGROUND: Hereditary angioedema (HAE) results from a genetic deficiency of C1-
inhibitor. Two similar independent, randomized, saline controlled, double-blind studies were …

These parameters were developed by the Joint Task Force on Practice Parameters (JTFPP),
representing the American Academy of Allergy, Asthma & Immunology (AAAAI); the …